619 related articles for article (PubMed ID: 35693341)
1. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
Xu YJ; Au NPB; Ma CHE
Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
[TBL] [Abstract][Full Text] [Related]
2. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
3. Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress.
Bisht K; Sharma K; Tremblay MÈ
Neurobiol Stress; 2018 Nov; 9():9-21. PubMed ID: 29992181
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease.
Sobue A; Komine O; Yamanaka K
Inflamm Regen; 2023 May; 43(1):26. PubMed ID: 37165437
[TBL] [Abstract][Full Text] [Related]
5. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
6. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
8. Zinc utilization by microglia in Alzheimer's disease.
Shippy DC; Oliai SF; Ulland TK
J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease.
Ohm DT; Fought AJ; Martersteck A; Coventry C; Sridhar J; Gefen T; Weintraub S; Bigio E; Mesulam MM; Rogalski E; Geula C
Brain Pathol; 2021 Jan; 31(1):189-204. PubMed ID: 33010092
[TBL] [Abstract][Full Text] [Related]
10. Microglia in Alzheimer's Disease in the Context of Tau Pathology.
Perea JR; Bolós M; Avila J
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066368
[TBL] [Abstract][Full Text] [Related]
11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer's Disease.
Yan H; Wang W; Cui T; Shao Y; Li M; Fang L; Feng L
Immunotargets Ther; 2024; 13():287-304. PubMed ID: 38881647
[TBL] [Abstract][Full Text] [Related]
14. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
Yang Y; Zhang Z
Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
[TBL] [Abstract][Full Text] [Related]
15. TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ
Akhter R; Shao Y; Formica S; Khrestian M; Bekris LM
Mol Immunol; 2021 Mar; 131():171-179. PubMed ID: 33461764
[TBL] [Abstract][Full Text] [Related]
16. [Pathological changes induced by amyloid-β in Alzheimer's disease].
Takata K; Kitamura Y; Taniguchi T
Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
[TBL] [Abstract][Full Text] [Related]
17. Microglial Immunometabolism in Alzheimer's Disease.
Shippy DC; Ulland TK
Front Cell Neurosci; 2020; 14():563446. PubMed ID: 33192310
[TBL] [Abstract][Full Text] [Related]
18. Microglia Polarization in Alzheimer's Disease: Mechanisms and a Potential Therapeutic Target.
Wang Q; Yao H; Liu W; Ya B; Cheng H; Xing Z; Wu Y
Front Aging Neurosci; 2021; 13():772717. PubMed ID: 34819850
[TBL] [Abstract][Full Text] [Related]
19. The Strategies for Treating "Alzheimer's Disease": Insulin Signaling May Be a Feasible Target.
You G; Yao J; Liu Q; Li N
Curr Issues Mol Biol; 2022 Dec; 44(12):6172-6188. PubMed ID: 36547082
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of microglial activity as a therapy for Alzheimer's disease.
Tan B; Choi RH; Chin TJ; Kaur C; Ling EA
Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
